BERLIN, 06.09. 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, announced today that it is hosting a policy roundtable with German regulators on the legalization of adult-use cannabis in Germany has Germany. At this meeting, the German drug commissioner Burkhard Blienert presented the plan to legalize cannabis for adults and confirmed the government’s announcement that a first draft law would be presented in the next few months. With this event, Tilray reaffirms its leadership as a trusted partner to government regulators and contributes to Germany’s legalization efforts by sharing its many years of expertise and experience in cannabis research, product quality and safety, supply management, patient and consumer protection, and cannabis education.

Attendees at the meeting included senior leaders from Germany’s health and legal committees, including:

• Burkhard Blienert, drug commissioner in the Federal Ministry of Health
• Kristine Lütke, MdB (FDP), spokeswoman on narcotics policy
• Carlos Kasper, MdB (SPD), finance committee
• Martina Stamm-Fibich, MdB (SPD), Health Committee

Denise Faltischek, Tilray Brands, Inc. Chief Strategy Officer and Chief International Officer, said, “We are honored to have initiated this high-level conversation about one of the most important global cannabis initiatives. As a leading global cannabis company, Tilray Brands has an unparalleled track record of partnering with…